• Innovative treatments for co-occurring disorders

Development and evaluation of integrated therapeutic approaches for individuals with concurrent mental health and substance use disorders, including the use of psychedelics and ketamine.

• Clinical acceptability and implementation of emerging interventions

Mixed-methods and qualitative research exploring clinicians’ perceptions, barriers, and facilitators to the integration of novel therapies—particularly in addiction and mental health care settings.

• Contextual factors influencing therapeutic outcomes

Investigation of non-pharmacological factors—such as music, therapeutic alliance, and setting—that modulate the therapeutic effects of psychedelic treatments.